Centene unexpectedly shows a quarterly loss

Centene Reports Unexpected Quarterly Loss

(Reuters) – Centene announced a surprising loss for the quarter, marking yet another setback for investors in the sector, who are grappling with increased costs associated with government-supported insurance plans.

The company’s stock plummeted 14.5% in pre-market trading, affecting other companies like Elevate and Morina Healthcare. This situation raises concerns about escalating costs for government-backed insurance schemes.

The insurance industry has faced challenges for the last two years, primarily due to rising healthcare expenses.

On one hand, insurance companies are pushing to expand the use of behavioral health services, home care, and expensive medications. On the other hand, the expiration of subsidies and Medicaid protections established during the pandemic has led to higher rates of enrollment among unhealthy members, which in turn has squeezed profit margins.

Focusing on government-sponsored plans, Centene reported a medical care ratio (MCR) of 93% for the quarter—significantly exceeding Wall Street’s expectation of 89.3% and indicating pressure across various business segments.

“While this quarter’s healthcare costs were unexpectedly high and seemed to affect all major business lines, their specific exchange businesses were likely the biggest contributors,” said Morningstar analyst Julie Attterback.

The quarterly losses were largely due to anticipated downward revisions of risk-adjusted revenues for 2025, part of the affordable care method that balances costs among insurers.

With increased Medicaid spending factored in, Centene’s loss rose to $0.86 per share, in comparison to a $0.16 per share loss in the previous quarter, based on data from LSEG.

“We’re disappointed with our second-quarter results, but we are aware of the urgent trends affecting our performance and are focused on restoring our revenue growth,” stated CEO Sarah London.

Centene plans to outline its revenue expectations for 2025 during an upcoming conference call.

The company is anticipating a premium increase for its Obama Care plans in 2026, as it expects a higher proportion of patients requiring increased medical care than had been forecasted previously.